fbpx

X

Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors – Xtalks Life Science Podcast Ep. 99

Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors – Xtalks Life Science Podcast Ep. 99

Doug Biehn, Chief Commercial Officer at Cala Health, discussed the benefits of Cala Trio for the relief of hand tremors in adults with essential tremor. Photos of Doug Biehn and Cala Trio courtesy of Cala Health.

In this week’s Xtalks Life Science podcast episode, Sarah spoke with Doug Biehn, Chief Commercial Officer at Cala Health, a bioelectronic medicine company that develops wearable neuromodulation therapies.

The company’s lead product, Cala Trio, was approved by the US Food and Drug Administration (FDA) in 2018 for transient relief of hand tremors in adults with essential tremor (ET).

Tune into the episode to learn more about Cala Health’s individualized prescription neuromodulation therapy. Doug discussed the day-to-day struggles of patients with ET and the challenges they face when seeking medication for their condition. Doug also shared the benefits of Cala Trio for the relief of hand tremors and how company is committed to ensuring all patients have access to this life-changing neuromodulation therapy.

Listen on Apple Podcasts

The weekly podcast is available for streaming every Wednesday on SpotifyApple Music and wherever you stream your podcasts.

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.